Renishaw neuromate — Specs & Review
Specifications
| Brand | Renishaw |
|---|---|
| Model | neuromate |
| Year | 1997 |
| Category | Medical |
| Autonomy | semi-autonomous |
| Environment | indoor |
| Price (USD) | $500000–$900000 |
| Dimensions | 85cm L × 70cm W × 170cm H |
| Connectivity | Ethernet, WiFi |
| Country of origin | GB |
Key features
- 0.5mm intracranial targeting accuracy
- DBS, SEEG and biopsy cleared
- 5-axis robotic guidance arm
- CT and MRI planning integration
- FDA cleared + CE marked
- 25+ years clinical heritage
- Renishaw precision engineering
What is it?
Renishaw neuromate is a robotic stereotactic neurosurgery system for intracranial procedures including deep brain stimulation, SEEG epilepsy electrode placement, and brain biopsy, with 0.5mm positioning accuracy.
Who is it for?
- Functional neurosurgeons performing deep brain stimulation for Parkinson's disease and tremor
- Epileptologists and epilepsy surgery teams planning SEEG electrode implantation
- Neurosurgeons performing stereotactic brain biopsies for tumour or lesion diagnosis
- Neurosurgery centres seeking a multi-application stereotactic robotic platform
Key specs
- Accuracy: 0.5mm intracranial targeting
- Arm: 5-axis robotic guidance
- Planning: CT + MRI integration
- Procedures: DBS, SEEG, biopsy
- Regulatory: FDA cleared + CE marked
- Track record: 25+ years clinical use
How it compares
Vs ROSA Brain (Zimmer Biomet): Both are robotic stereotactic platforms. neuromate has a longer clinical history; ROSA Brain is a newer platform with a more modern interface. Both are cleared for DBS and SEEG with similar accuracy specifications.
Limitations
- Smaller market presence than general surgical robot platforms
- 0.5mm accuracy, while excellent, is similar to competing stereotactic platforms
- Limited to neurosurgical applications — no multi-specialty capability
- Requires dedicated neurosurgery suite integration
FAQ
How much does the Renishaw neuromate cost?
Renishaw neuromate pricing is available through Renishaw's neurosurgery sales network. Neurosurgical robotic systems are priced at $500,000–$900,000. Contact Renishaw for formal pricing.
What is the Renishaw neuromate used for?
neuromate is a robotic neurosurgical system for stereotactic procedures including deep brain stimulation (DBS) electrode placement, stereoelectroencephalography (SEEG) for epilepsy, and brain biopsies — guiding instruments to precise intracranial targets.
What are the key specs of the neuromate?
neuromate provides 0.5mm positioning accuracy for intracranial targets, integrates with CT and MRI pre-operative planning, uses a 5-axis robotic arm for instrument guidance, and has FDA clearance and CE marking for stereotactic neurosurgery.
Who uses the Renishaw neuromate?
neuromate is used by functional neurosurgeons performing DBS for Parkinson's disease and tremor, epileptologists planning SEEG electrode implantation for epilepsy localisation, and neurosurgeons performing stereotactic brain biopsies.
What distinguishes the Renishaw neuromate in the neurosurgery robot market?
neuromate is one of the longest-established neurosurgical robots with a clinical track record spanning 25+ years. Most neurosurgical robots focus on single applications; neuromate is cleared for DBS, SEEG, and biopsy in a single platform.